Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Arsobal
2. Mel B
3. Melarsenoxid Bal
4. Melarsenoxid-bal
5. Melarsenoxidbal
1. 494-79-1
2. Mel B
3. Arsobal
4. Melarsoprolum [inn-latin]
5. Rp 3854
6. Einecs 207-793-4
7. Rp-3854
8. [2-[4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-1,3,2-dithiarsolan-4-yl]methanol
9. Chebi:6729
10. Zf3786q2e8
11. Melarsoprol (inn)
12. Melarsoprol [inn]
13. 2-(p-(4,6-diamino-s-triazin-2-ylamino)phenyl)-1,3,2-dithiarsolane-4-methanol
14. Melarsoprolum
15. (2-(4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)-1,3,2-dithiarsolan-4-yl)methanol
16. (2-{4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl}-1,3,2-dithiarsolan-4-yl)methanol
17. Melarsoprol [inn:ban:dcf]
18. Specia
19. Unii-zf3786q2e8
20. Melarsoprol [mi]
21. Mel B (tn)
22. Chembl166
23. 1,3,2-dithiarsolane-4-methanol, 2-(4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)-
24. Melarsoprol [mart.]
25. Schembl61707
26. Melarsoprol [who-dd]
27. Dtxsid90862033
28. Db12864
29. C08001
30. D00832
31. Q419753
32. 2-[4-{(4,6-diamino-1,3,5-triazin-2-yl)amino}phenyl]-1,3,2-dithiarsolan-e-4-methanol
| Molecular Weight | 398.3 g/mol |
|---|---|
| Molecular Formula | C12H15AsN6OS2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 397.996471 g/mol |
| Monoisotopic Mass | 397.996471 g/mol |
| Topological Polar Surface Area | 174 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 353 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Trypanocidal Agents
Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01C - Agents against leishmaniasis and trypanosomiasis
P01CD - Arsenic compounds
P01CD01 - Melarsoprol
Market Place
ABOUT THIS PAGE
85
PharmaCompass offers a list of Melarsoprol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Melarsoprol manufacturer or Melarsoprol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Melarsoprol manufacturer or Melarsoprol supplier.
PharmaCompass also assists you with knowing the Melarsoprol API Price utilized in the formulation of products. Melarsoprol API Price is not always fixed or binding as the Melarsoprol Price is obtained through a variety of data sources. The Melarsoprol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Melarsoprol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Melarsoprol, including repackagers and relabelers. The FDA regulates Melarsoprol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Melarsoprol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Melarsoprol supplier is an individual or a company that provides Melarsoprol active pharmaceutical ingredient (API) or Melarsoprol finished formulations upon request. The Melarsoprol suppliers may include Melarsoprol API manufacturers, exporters, distributors and traders.
Melarsoprol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Melarsoprol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Melarsoprol GMP manufacturer or Melarsoprol GMP API supplier for your needs.
A Melarsoprol CoA (Certificate of Analysis) is a formal document that attests to Melarsoprol's compliance with Melarsoprol specifications and serves as a tool for batch-level quality control.
Melarsoprol CoA mostly includes findings from lab analyses of a specific batch. For each Melarsoprol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Melarsoprol may be tested according to a variety of international standards, such as European Pharmacopoeia (Melarsoprol EP), Melarsoprol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Melarsoprol USP).
